Loading...
VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
BACKGROUND: The probiotic mixture VSL#3 has proven efficacious in inflammatory bowel diseases and irritable bowel syndrome; however, its efficacy in microscopic colitis (MC) is being investigated. OBJECTIVE: To evaluate the safety and efficacy of a multistrain probiotic, VSL#3, in inducing clinical...
Na minha lista:
| Udgivet i: | BMJ Open Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599154/ https://ncbi.nlm.nih.gov/pubmed/26462271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|